Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B- irradiated psoriatic plaques express fas ligand (CD95L)

Journal of Clinical Investigation

Volumn 101, Issue 1, 1998, Pages 33-39

  Gutierrez Steil, Christina ^a   Wrone Smith, Tamara ^a   Sun, Xiaoming ^a   Krueger, James G ^b   Coven, Todd ^b   Nickoloff, Brian J ^a,c  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; CD95; CD95L; Keratinocytes; Skin cancer

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ANTIGEN EXPRESSION; ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; KERATINOCYTE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; RADIATION CARCINOGENESIS; SUNLIGHT; ULTRAVIOLET B RADIATION;

EID: 0031974704     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1165     Document Type: Article

References (32)

1. Miller, D.L., and M.A. Weinstock. 1994. Nonmelanoma skin cancer in the United States: incidence. J. Am. Acad. Dermatol. 30:774-778.
2. Taylor, R.S. C.E.M. Griffiths, M. Brown, N. Swanson, and B.J. Nickoloff. 1990. Constitutive absence and interferon-gamma induction of expression of adhesion molecules in basal cell carcinoma. J. Am. Acad. Dermatol. 22:721-726.
3. Kim, J., R.L. Modlin, R.L. Moy, S.M. Dubinett, T. McHugh, B.J. Nickoloff, and K. Uyemura. 1995. IL-10 production in cutaneous basal and squamous cell carcinoma. A mechanism for evading the local T cell immune response. J. Immunol. 155:2240-2247.
4. Mitra, R.S., L.A. Turka, T.A. Judge, F.O. Nestle, and B.J. Nickoloff. 1995. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J. Immunol. 154:2668-2677.
5. Nestle, F.O., G. Burg, J. Fah, T. Wrone-Smith, and B.J. Nickoloff. 1997. Human sunlight-induced basal cell carcinoma are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am. J. Pathol. 150: 1-11.
6. Nakagawa, K., K. Yamamura, S. Maeda, and M. Ichihashi. 1994. Bcl-2 expression in epidermal keratinocyte diseases. Cancer. 74:1720-1724.
7. Oishi, M., K. Maeda, and S. Sugiyama. 1994. Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocytes and squamous carcinoma cell lines. Arch. Dermatol. Res. 286:396-407.
8. Wrone-Smith, T., G. Nunez, T. Johnson, B. Nelson, L.H. Boise, C.B. Thompson, and B.J. Nickoloff. 1995. Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am. J. Pathol. 146:1-10.
9. Lynch, D.H., F. Ramsdell, and M.R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today. 16:569-574.
10. Van Parijs, L., A. Ibraghimov, and A.K. Abbas. 1996. The roles of co-stimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity. 4: 321-328.
11. Nickoloff, B.J., R.S. Mitra, J. Green, C. Thompson, L. Turka, and Y. Shimizu. 1993. Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo. Am. J. Pathol. 142:1029-1040.
12. Nickoloff, B.J., and L.A. Turka. 1994. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol. Today. 15:464-169.
13. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747-1756.
14. Trauth, B.C., C. Klas, A.M. Peters, S. Matzku, P. Moller, W. Falk, K.M. Debatin, and P.H. Kramer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science. 245:301-305.
15. Krueger, J.G., J.T. Wolfe, R.T. Nabeya, V.P. Vallat, P. Gilleaudeau, N.S. Heftler, L.M. Austin, and A.B. Gottlieb. 1995. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J. Exp. Med. 182:2057-2068.
16. Boukamp, P., R.T. Petrussevska, D. Breitcreutz, J. Hornung, A. Marhan, and N.E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell. Biol. 106:761-777.
17. O'Connell, J., G.C. O'Sullivan, J.K. Collins, and F. Shanahan. 1996. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184:1075-1082.
18. Mariani, S.M., B. Matiba, C. Baumler, and P.H. Krammer. 1995. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol. 25:2303-2307.
19. Arai, H., S.Y. Chan, D.K. Bishop, and G.J. Nabel. 1997. Inhibition of the alloantibody response by CD95 ligand. Nat. Med. 3:843-848.
20. Liles, W.C., J.A. Ledbetter, A.W. Waltersdorph, and S.J. Klebanoff. 1995. Crosslinking of CD45 enhances activation of the respiratory burst in response to specific stimuli in human phagocytes. J. Immunol. 155:2175-2184.
21. Oshimi, Y., S. Oda, Y. Honda, S. Nagata, and S. Miyayaki. 1996. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J. Immunol. 157:2909-2915.
22. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1169-1178.
23. Griffith, T.S., T. Brunner, S.M. Fletcher, D.R. Green, and T.A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1189-1192.
24. Zierhut, M., T. Bieber, E.B. Brocker, J.U. Forrester, C.S. Foster, and J.W. Streilein. 1996. Immunology of the skin and the eye. Immunol. Today. 17: 448-450.
25. Hahne, M., D. Rimoldi, M. Schroter, P. Romero, M. Schreier, L.E. French, P. Schneider, T. Bornard, A. Fontana, D. Lienard, et al. 1996. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science. 274:1363-1366.
26. Strand, S., W.J. Hofmann, H. Hug, M. Muller, G. Otto, D. Strand, S.M. Mariani, W. Stremmel, P.H. Krammer, and P.R. Galle. 1996. Lymphocyte apoptosis induced by CD95 (Apo-1/Fas) ligand-expressing tumor cells. A mechanism of immune evasion? Nat. Med. 2:1361-1366.
27. Yuspa, S.H. 1994. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis - thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Res. 54:1178-1189.
28. Barker, J.N., R.S. Mitra, C.E.M. Griffiths, V.M. Dixit, and B.J. Nickoloff. 1991. Keratinocytes as initiators of inflammation. Lancet. 337:211-214.
29. Wrone-Smith, T., R.S. Mitra, C.B. Thompson, R. Jasty, V.P. Castle, and B.J. Nickoloff. 1997. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am. J. Pathol. 151:1321-1329.
30. Wrone-Smith, T., and B.J. Nickoloff. 1996. Dermal injection of immunocytes induces psoriasis. J. Clin. Invest. 98:1879-1887.
31. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today. 16:39-43.
32. Nickoloff, B.J., and L.A. Turka. 1993. Keratinocytes: key immunocytes of the integument. Am. J. Pathol. 143:325-331.